295 related articles for article (PubMed ID: 1647298)
1. High activity of low-Michaelis-Menten constant 3', 5'-cyclic adenosine monophosphate-phosphodiesterase isozymes in renal inner medulla of mice with hereditary nephrogenic diabetes insipidus.
Takeda S; Lin CT; Morgano PG; McIntyre SJ; Dousa TP
Endocrinology; 1991 Jul; 129(1):287-94. PubMed ID: 1647298
[TBL] [Abstract][Full Text] [Related]
2. Role of cAMP-phosphodiesterase isozymes in pathogenesis of murine nephrogenic diabetes insipidus.
Homma S; Gapstur SM; Coffey A; Valtin H; Dousa TP
Am J Physiol; 1991 Aug; 261(2 Pt 2):F345-53. PubMed ID: 1652209
[TBL] [Abstract][Full Text] [Related]
3. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
Torphy TJ; Cieslinski LB
Mol Pharmacol; 1990 Feb; 37(2):206-14. PubMed ID: 2154670
[TBL] [Abstract][Full Text] [Related]
4. Induction of intramembranous particle clusters in mice with nephrogenic diabetes insipidus.
Coffey AK; O'Sullivan DJ; Homma S; Dousa TP; Valtin H
Am J Physiol; 1991 Oct; 261(4 Pt 2):F640-6. PubMed ID: 1656782
[TBL] [Abstract][Full Text] [Related]
5. Role of phosphodiesterase isoenzymes in regulating intracellular cyclic AMP in adenosine-stimulated smooth muscle cells.
Xiong Y; Westhead EW; Slakey LL
Biochem J; 1995 Jan; 305 ( Pt 2)(Pt 2):627-33. PubMed ID: 7832782
[TBL] [Abstract][Full Text] [Related]
6. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro.
Truss MC; Uckert S; Stief CG; Schulz-Knappe P; Hess R; Forssmann WG; Jonas U
Urology; 1995 May; 45(5):893-901. PubMed ID: 7747383
[TBL] [Abstract][Full Text] [Related]
7. Distinct profiles of phosphodiesterase isozymes in cultured cells derived from nonpigmented and pigmented ocular ciliary epithelium.
Bode DC; Hamel LT; Wax MB
J Pharmacol Exp Ther; 1993 Dec; 267(3):1286-91. PubMed ID: 8263791
[TBL] [Abstract][Full Text] [Related]
8. Cyclic nucleotide phosphodiesterases from frog atrial fibers: isolation and drug sensitivities.
Lugnier C; Gauthier C; Le Bec A; Soustre H
Am J Physiol; 1992 Mar; 262(3 Pt 2):H654-60. PubMed ID: 1373036
[TBL] [Abstract][Full Text] [Related]
9. Cyclic AMP-dependent phosphodiesterase isozyme-specific potentiation by protein kinase C in hypertrophic cardiomyopathic hamster hearts.
Yu H; Cai JJ; Lee HC
Mol Pharmacol; 1996 Sep; 50(3):549-55. PubMed ID: 8794893
[TBL] [Abstract][Full Text] [Related]
10. Cyclic-3',5'-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney.
Dousa TP
Kidney Int; 1999 Jan; 55(1):29-62. PubMed ID: 9893113
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of beta adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity.
Torphy TJ; Zhou HL; Cieslinski LB
J Pharmacol Exp Ther; 1992 Dec; 263(3):1195-205. PubMed ID: 1335058
[TBL] [Abstract][Full Text] [Related]
12. Evidence for the activity of five adenosine-3',5'-monophosphate-degrading phosphodiesterase isozymes in the adult rat neocortex.
Sutor B; Mantell K; Bacher B
Neurosci Lett; 1998 Aug; 252(1):57-60. PubMed ID: 9756358
[TBL] [Abstract][Full Text] [Related]
13. Causes of the urinary concentrating defect in mice with nephrogenic diabetes insipidus.
Valtin H; Coffey AK; O'Sullivan DJ; Homma S; Dousa TP
Physiol Bohemoslov; 1990; 39(1):103-11. PubMed ID: 2165265
[TBL] [Abstract][Full Text] [Related]
14. Cellular action of vasopressin in medullary tubules of mice with hereditary nephrogenic diabetes insipidus.
Jackson BA; Edwards RM; Valtin H; Dousa TP
J Clin Invest; 1980 Jul; 66(1):110-22. PubMed ID: 6249843
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and pharmacological characterization of cyclic nucleotide phosphodiesterase in airway epithelium.
Rousseau E; Gagnon J; Lugnier C
Mol Cell Biochem; 1994 Nov; 140(2):171-5. PubMed ID: 7898488
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of cyclic nucleotide phosphodiesterase isozymes type-III and type-IV suppress mitogenesis of rat mesangial cells.
Matousovic K; Grande JP; Chini CC; Chini EN; Dousa TP
J Clin Invest; 1995 Jul; 96(1):401-10. PubMed ID: 7615811
[TBL] [Abstract][Full Text] [Related]
17. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.
Lavan BE; Lakey T; Houslay MD
Biochem Pharmacol; 1989 Nov; 38(22):4123-36. PubMed ID: 2480793
[TBL] [Abstract][Full Text] [Related]
18. Localization of low-KM cAMP phosphodiesterase in rat nephron segments.
Yoshida I; Takeda S; Homma S; Kusano E; Asano Y
Kidney Blood Press Res; 1997; 20(5):307-11. PubMed ID: 9419046
[TBL] [Abstract][Full Text] [Related]
19. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
Marcoz P; Prigent AF; Lagarde M; Nemoz G
Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
[TBL] [Abstract][Full Text] [Related]
20. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells.
Souness JE; Diocee BK; Martin W; Moodie SA
Biochem J; 1990 Feb; 266(1):127-32. PubMed ID: 2155604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]